High Granular Tick Data API: US Stocks Learn more

Try our APIs with free plan!

PROQR THERAPEUTICS EO-04 Financial Data Overview

Price chart is built with Anychart
ISIN: NL001087**** The data is available with plans that include the Fundamentals API. Check our pricing page for details.

ProQR Therapeutics N.V., a clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company develops an RNA editing platform through its Axiomer RNA editing technology for genetic disorders with unmet needs. Its lead product candidate, AX-0810, targets na-taurocholate cotransporting polypeptide (NTCP) for the treatment of cholestatic diseases. The company also develops AX-2402, which targets methyl CpG binding protein 2 mutations for Rett syndrome; AX-2911, which targets PNPLA3 for metabolic dysfunction-associated steatohepatitis; and AX-1412, which targets the B4GALT1 gene for cardiovascular diseases. It has a research and collaboration agreement with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. The company was incorporated in 2012 and is headquartered in Leiden, the Netherlands.

Prev. Close 1.5194
Open 1.5194
High 1.5194
Low 1.5194
52 wk Range 0.9545-2.558
Market Cap 161 M
Shares Outstanding 105 M
Revenue 16 347 K
Beta 0.093

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get PROQR THERAPEUTICS EO-04 data using free add-ons & libraries


Get PROQR THERAPEUTICS EO-04 Fundamental Data

PROQR THERAPEUTICS EO-04 Fundamental data includes:

  • Net Revenue: 16 347 K
  • EBITDA: -42 544 000
  • Earnings Per Share:
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get PROQR THERAPEUTICS EO-04 Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2026-03-12
  • EPS/Forecast: -0.18
GET THE PACKAGE

Get PROQR THERAPEUTICS EO-04 End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE
Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat

Send the request

Leave your email and our team will contact you ASAP.